Evidence map›Paper›PMID 28642699›Full record

ArticleFrontiers in aging neuroscience2017

Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults.

Katherine J Bangen, Alexandra L Clark, Emily C Edmonds, Nicole D Evangelista, Madeleine L Werhane, Kelsey R Thomas, Lyzette E Locano, My Tran, Zvinka Z Zlatar, Daniel A Nation and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Cerebral blood flow as a biomarker of resilience in cognitively unimpaired APOE ɛ4 carriers.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Multimodal neuroimaging insights into the neurobiology of healthy aging across the lifespan.European journal of nuclear medicine and molecular imaging · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Evidence of cerebral hemodynamic dysregulation in middle-aged APOE ε4 carriers: The PREVENT-Dementia study.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Katherine J BangenResearch Service, VA San Diego Healthcare System, San DiegoCA, United States.
Alexandra L ClarkSan Diego State University, University of California, San Diego Joint Doctoral Program in Clinical Psychology, San DiegoCA, United States.
Emily C EdmondsResearch Service, VA San Diego Healthcare System, San DiegoCA, United States.
Nicole D EvangelistaResearch Service, VA San Diego Healthcare System, San DiegoCA, United States.
Madeleine L WerhaneSan Diego State University, University of California, San Diego Joint Doctoral Program in Clinical Psychology, San DiegoCA, United States.
Kelsey R ThomasResearch Service, VA San Diego Healthcare System, San DiegoCA, United States.
Lyzette E LocanoDepartment of Psychology, San Diego State University, San DiegoCA, United States.
My TranDepartment of Psychology, San Diego State University, San DiegoCA, United States.
Zvinka Z ZlatarDepartment of Psychiatry, University of California, San Diego, La JollaCA, United States.
Daniel A NationDepartment of Psychology, University of Southern California, Los AngelesCA, United States.
Mark W BondiDepartment of Psychiatry, University of California, San Diego, La JollaCA, United States.
Lisa Delano-WoodResearch Service, VA San Diego Healthcare System, San DiegoCA, United States.
University of California, San Diego · USSan Diego State University · USVA San Diego Healthcare System · USUniversity of Southern California · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
VIRUS-INDUCED BRAIN PATHOLOGYP50AG005131 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BREWER, JAMES B · 1985 to 2018
$55.4M
VASCULAR RISK AND COGNITIVE STATUS IN A LATINO POPULATIONP50AG005142 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BRASKIE, MEREDITH NICOLE · 1985 to 2019
$41.0M
Re-visiting Methods for MCI Diagnosis to Improve Biomarker and Trial FindingsR01AG049810 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BONDI, MARK W, EDLAND, STEVEN DYAL · 2016 to 2020
$3.7M
Neuroimaging and Risk Factor Correlates in Aging and MCIK24AG026431 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BONDI, MARK W · 2007 to 2016
$1.7M
A Novel Mobile Health Exercise Intervention in Aging: Brain Perfusion and CognitionK23AG049906 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZLATAR, ZVINKA ZOE · 2016 to 2022
$888k
Vascular Reserve and Protective Mechanisms in Aging and Alzheimer’s Dementia RiskR21AG055034 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI NATION, DANIEL A · 2017 to 2018
$454k
Neuroimaging and Vascular Correlates of Mild Cognitive Impairment SubtypesIK2CX000938 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI BANGEN, KATHERINE · 2015 to 2019
–
Cognitive and Biomarker Profiles of Accurate and Inaccurate MCI DiagnosisIK2CX001415 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI EDMONDS, EMILY CHARLOTTE · 2017 to 2021
–
CSRD VA IK2 CX000938CSRD VA IK2 CX001415NIA NIH HHS K23 AG049906NIA NIH HHS K24 AG026431NIA NIH HHS P50 AG005131NIA NIH HHS P50 AG005142NIA NIH HHS R01 AG049810NIA NIH HHS R21 AG055034NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

Cerebral blood flow (CBF) alterations and amyloid-β (Aβ) accumulation have been independently linked to cognitive deficits in older adults at risk for dementia. Less is known about how CBF and Aβ may interact to affect cognition in cognitively normal older adults. Therefore, we examined potential statistical interactions between CBF and Aβ status in regions typically affected in Alzheimer's disease (AD) within a sample of older adults from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study. Sixty-two cognitively normal participants (mean age = 72 years) underwent neuroimaging and memory testing. Arterial spin labeling magnetic resonance imaging was used to quantify CBF and florbetapir PET amyloid imaging was used to measure Aβ deposition. Aβ status (i.e., positivity versus negativity) was determined based on established cutoffs (Landau et al., 2013). The Rey Auditory Verbal Learning Test was used to assess memory. Linear regression models adjusted for age, education, and sex, demonstrated significant interactions between CBF and Aβ status on memory performance. Among Aβ positive older adults, there were significant negative associations between higher CBF in hippocampus, posterior cingulate, and precuneus and poorer memory performance. In contrast, among Aβ negative older adults, there were no significant associations between CBF and cognition. Our findings extend previous CBF studies of dementia risk by reporting interactions between Aβ status and CBF on memory performance in a sample of well-characterized, cognitively normal older adults. Results suggest that differential CBF-cognition associations can be identified in healthy, asymptomatic Aβ positive older adults relative to Aβ negative individuals. Associations between higherCBF and poorer memory among Aβ positive older adults may reflect a cellular and/or vascular compensatory response to pathologic processes whereby higher CBF is needed to maintain normal memory abilities. Findings indicate that CBF and its associations with cognition may have utility as a reliable marker of brain function early in the AD process when interventions are likely to be beneficial.

Indexed as

agingAlzheimer’s diseaseamyloidarterial spin labeling (ASL)cerebral blood flowmemoryneuroimagingpositron emission tomography (PET)

Identifiers

PMID28642699
PMCPMC5463038
OpenAlexW2623509113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.